ArticleAllergy and asthma proceedings2018

Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States.

Jacqueline Eghrari-Sabet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.